Literature DB >> 3756069

Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies.

J Y Jeremy, M A Barradas, D P Mikhailidis, P Dandona.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3756069      PMCID： PMC1401114          DOI： 10.1111/j.1365-2125.1986.tb05252.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  10 in total

1.  The effect of nifedipine, nimodipine and nisoldipine on agonist- and trauma-stimulated vascular prostacyclin synthesis in vitro.

Authors:  J Y Jeremy; D P Mikhailidis; P Dandona
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-01       Impact factor: 3.000

2.  Ex vivo effects of nifedipine, nisoldipine and nitrendipine on filterability of red blood cells from healthy volunteers.

Authors:  S O Sowemimo-Coker; N M Debbas; I B Kovacs; P Turner
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

3.  Effect of ethanol on vascular prostacyclin (prostaglandin I2) synthesis, platelet aggregation, and platelet thromboxane release.

Authors:  D P Mikhailidis; J Y Jeremy; M A Barradas; N Green; P Dandona
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-19

4.  The rat urinary bladder produces prostacyclin as well as other prostaglandins.

Authors:  J Y Jeremy; D P Mikhailidis; P Dandona
Journal:  Prostaglandins Leukot Med       Date:  1984-11

5.  Prostacyclin is not a circulating hormone in man.

Authors:  I A Blair; S E Barrow; K A Waddell; P J Lewis; C T Dollery
Journal:  Prostaglandins       Date:  1982-04

6.  Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies.

Authors:  C R Jones; F Pasanisi; H L Elliott; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1985-09       Impact factor: 4.335

7.  Adrenergic modulation of vascular prostacyclin (PGI2) secretion.

Authors:  J Y Jeremy; D P Mikhailidis; P Dandona
Journal:  Eur J Pharmacol       Date:  1985-08-07       Impact factor: 4.432

8.  Thromboxane A2 analogue (U-46619) stimulates vascular PGI2 synthesis.

Authors:  J Y Jeremy; D P Mikhailidis; P Dandona
Journal:  Eur J Pharmacol       Date:  1985-01-02       Impact factor: 4.432

9.  An investigation into the effects of nifedipine and nimodipine on platelet function and vascular prostacyclin synthesis.

Authors:  J Y Jeremy; M A Barradas; D P Mikhailidis; P Dandona
Journal:  Drugs Exp Clin Res       Date:  1985

10.  The interrelationship between thromboxane biosynthesis, aggregation and 5-hydroxytryptamine secretion in human platelets in vitro.

Authors:  L C Best; T K Holland; P B Jones; R G Russell
Journal:  Thromb Haemost       Date:  1980-02-29       Impact factor: 5.249
  10 in total
  3 in total

Review 1.  Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  H A Friedel; E M Sorkin
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

Review 2.  Nisoldipine coat-core. A review of its pharmacology and therapeutic efficacy in hypertension.

Authors:  G L Plosker; D Faulds
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

3.  Nisoldipine in primary Raynaud's phenomenon.

Authors:  V F Challenor; D G Waller; D A Francis; J L Francis; R Mani; S Roath
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.